HYPERION THERAPEUTICS INC — Form D

HYPERION THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-16. The offering totals $45.5M, of which $22.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Jim HealyDirectorSan Francisco, CA
Daniel PerezDirectorSan Francisco, CA
Toni MartinezExecutive OfficerSouth San Francisco, CA
Gaurav AggarwalDirectorPalo Alto, CA
Rob HopfnerDirectorSan Diego, CA
James I HealyDirectorDORADO, PR
Robert HopfnerDirectorPalo Alto, CA
James HealyDirectorSunnyvale, CA
CHRISTINE A NASHExecutive OfficerNEW HAVEN, CT
Donald J SantelExecutive OfficerSan Diego, CA
David GryskaDirectorDallas, TX
Donald SantelDirectorSan Diego, CA
Donald SantelExecutive OfficerSan Diego, CA
Bijan SalehizadehDirectorBETHESDA, MD
Jake NunnDirectorMenlo Park, CA
Jake R NunnDirectorSan Diego, CA
Bijan R SalehizadehDirectorChicago, IL
Bo Jesper HansenDirectorWestlake Village, CA
Lota S ZothDirectorLa Jolla, CA
Bo Jesper I HansenDirectorBrisbane, CA
Natalie A HollesExecutive OfficerBrisbane, CA
Daniel G WelchDirectorBrisbane, CA
Ashley A GouldExecutive OfficerBrisbane, CA
Klara A DickinsonExecutive OfficerBrisbane, CA
Bruce F ScharschmidtExecutive OfficerBrisbane, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2014-06-18D$8.0M$8.0M
2011-11-04D$15.0M$7.5M
2011-04-18D$35.0M$17.5M
2009-05-14D$15.0M$13.0M

More